Galena Biopharma Inc
Change company Symbol lookup
Select an option...
GALE Galena Biopharma Inc
WHR Whirlpool Corp
LGNYZ Ligand Pharmaceuticals Inc
XXNCC Del Taco Restaurant Properties I
TEHG Technovative Group Inc
PCG-G Pacific Gas and Electric Co
PAGP Plains GP Holdings LP
STND Standard Financial Corp
FNMAK Federal National Mortgage Association
PEBO Peoples Bancorp Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Galena Biopharma, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing targeted oncology therapeutics. Its development portfolio ranges from mid- to late-stage clinical assets, including immunotherapy program led by its lead product NeuVax (nelipepimut-S), which is in Phase III clinical trial and is a targeted cancer immunotherapy. NeuVax is the immunodominant nonapeptide derived from the extracellular domain of the HER2 protein, a target for therapeutic intervention in breast and gastric carcinomas. GALE-301 is an immunogenic peptide and can stimulate cytotoxic T lymphocytes to recognize and destroy Folate Binding Protein-expressing cancer cells. GALE-401 is a controlled release formulation of anagrelide. Its commercial drug, Abstral (fentanyl) Sublingual Tablets is a treatment option for inadequately controlled breakthrough cancer pain.

Closing Price
$0.6711
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.6888
Day's Low
0.60
Volume
4,492
  • Prev Close
    0.6711
  • Today's Open
    0.00
  • Day's Range
    0.60-0.6888
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    12:00a ET 02/09/16
  • Last (size)
    0
  • 52-Wk Range
    0.5855 - 2.39
    LowHigh
  • (06/08/15 - 02/03/16)
    14.62%
  • 73.1%
  • Market Cap
    108.7M
  • Shares Outstanding
    161.9M
  • -0.24
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.2
  • 14.15
  • (% of float 01/29/16)
    9.96

Latest News

February 08, 2016
7:05 am ET
Globe Newswire
February 02, 2016
7:05 am ET
Globe Newswire
January 21, 2016
4:10 pm ET
Globe Newswire
January 13, 2016
7:05 am ET
Globe Newswire
January 11, 2016
7:05 am ET
Globe Newswire
January 07, 2016
9:25 am ET
Globe Newswire
January 06, 2016
4:26 pm ET
Globe Newswire
December 31, 2015
12:31 pm ET
Zacks
December 30, 2015
2:00 am ET
Globe Newswire
December 24, 2015
7:05 am ET
Globe Newswire
December 18, 2015
7:05 am ET
Globe Newswire
2:00 am ET
Globe Newswire
December 14, 2015
8:54 am ET
Zacks
December 11, 2015
7:05 am ET
Globe Newswire
December 08, 2015
7:05 am ET
Globe Newswire
December 04, 2015
7:05 am ET
Globe Newswire
November 30, 2015
7:05 am ET
Globe Newswire
November 20, 2015
7:05 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.